Page 4 - பென்சில்வேனியா உயிரி தொழில்நுட்பவியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Dechert signs short-term lease renewal at Cira Centre in Philadelphia - Philadelphia Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Top 10 U S Biopharma Clusters
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Reply
(Shutterstock)
BUCKS COUNTY State Sen. Steve Santarsiero (D-10) and five health officials will discuss the rollout of the state s COVID-19 vaccine distribution plan during a town hall meeting.
The telephone town hall will take place at 7 p.m. on Thursday, Jan. 28. Residents can sign up for the town hall here. For those who can t attend, a recording will be made available here on Friday.
During the town hall, officials will provide local updates on when, how and where residents of the 10th Senate District, which includes a large portion of Bucks County, can get vaccinated.
Subscribe I am hearing from my constituents daily with questions about how they can get the COVID-19 vaccine, and when they will be eligible under state guidelines, Sen. Santarsiero said in a news release. I hope this town hall offers residents of my district an opportunity to get up to speed on the latest news about the vaccination effort, and have their questions answered.
Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
DOYLESTOWN, Pa., Jan. 19, 2021
Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the publication of its global
WIPO/PCT Patent WO 2020/ 264324 – “Use of Certain Phosphatidylcholines Containing Long Chain Polyunsaturated Fatty Acids (“PUFAs”) as Neuroprotective Agents” (the “PUFA Patent”).
The invention underlying the PUFA Patent relates to the pharmaceutical composition comprising an amount of phosphatidylcholine (“PC”) containing long chain polyunsaturated fatty acids as neuroprotective agents and to compositions and methods comprising the same (“NPTX-204”). It has surprisingly been discovered that certain PCs containing PUFAs exhibit neuroprotective effects on neuronal tissues subjected to oxidative stress. NPTX-204 and other PCs demonstrated
Bucks County Courier Times
DOYLESTOWN Hepatitis B Foundation co-founders Joan and Timothy Block were presented with the inaugural Distinguished Advocacy Service Award during the annual meeting of the American Association for the Study of Liver Diseases, or AASLD.
The Blocks were recognized for their efforts to raise awareness and prioritization of hepatitis B, and to ensure that the 2 million people living with hepatitis B in the U.S. have unhindered access to screening, appropriate medical care and treatment.
AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease.
The Hepatitis B Foundation, headquartered in the Pennsylvania Biotechnology Center in Buckingham, is a nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide.
vimarsana © 2020. All Rights Reserved.